CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-12 | Ketchum Steven B Chief Scientific Officer | Sale 10b5-1 | −34,131 | $0.79 | $27K | 566,100 |
| 2021-08-12 | Kalb Michael Wayne SVP and CFO | Sale | −120,000 | $5.25 | $630K | 205,010 |
| 2021-02-01 | Ketchum Steven B Chief Scientific Officer | Sale | −192,358 | $8.06 | $1.6M | 408,366 |
| 2021-02-01 | Ketchum Steven B Chief Scientific Officer | Sale | −25,370 | $8.03 | $204K | 382,996 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Sale | −278,237 | $8.01 | $2.2M | 531,504 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Sale | −143,392 | $8.01 | $1.1M | 388,112 |
| 2020-11-11 | THERO JOHN F President and CEO | Sale | −413,565 | $4.07 | $1.7M | 2,739,000 |
| 2020-11-10 | THERO JOHN F President and CEO | Sale | −153,840 | $4.13 | $636K | 3,152,565 |
| 2020-03-04 | THERO JOHN F President and CEO | Sale | −200,000 | $15.99 | $3.2M | 2,480,441 |
| 2020-01-03 | Zakrzewski Joseph S Director | Sale | −300,000 | $20.94 | $6.3M | 84,547 |
| 2019-12-16 | Zakrzewski Joseph S Director | Sale | −100,000 | $25.83 | $2.6M | 84,547 |
| 2019-12-16 | Berg Aaron CHIEF COMMERCIAL OFFICER | Sale | −43,253 | $25.46 | $1.1M | 133,806 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −16,400 | $23.05 | $378K | 30,152 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −7,500 | $23.81 | $179K | 22,652 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −1,000 | $24.84 | $25K | 21,652 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −100 | $25.66 | $3K | 21,552 |
| 2019-11-19 | THERO JOHN F President and CEO | Sale | −274,454 | $22.65 | $6.2M | 2,342,285 |
| 2019-11-12 | Ekman Lars Director | Sale | −38,600 | $19.35 | $747K | 0 |
| 2019-11-11 | THERO JOHN F President and CEO | Sale | −433,805 | $17.05 | $7.4M | 2,658,480 |
| 2019-11-11 | THERO JOHN F President and CEO | Sale | −41,741 | $17.88 | $746K | 2,616,739 |
Page 1 of 3 · 42 trades